Science
Mechanism of Action
Tetrahydropalmatine HCL exerts anti-inflammatory effects by inhibiting pro-inflammatory mediators such as IL-8 production and blocking MAPK phosphorylation in LPS-stimulated THP-1 cells. Furthermore, it demonstrates the ability to inhibit osteoclast formation in vitro. Its broader pharmacological profile includes antagonism of dopamine, alpha adrenergic, and serotonin receptors, as well as calcium channel blocking, though the precise topical mechanisms relevant to skin benefit are not fully elucidated.
Research
Clinical Evidence
Low confidenceN/A
Key findings
- 01 Inhibition of osteoclast formation in vitro without cytotoxicity at concentrations less than 19.00 µg/ml.
- 02 Dose-dependent inhibition of LPS-induced IL-8 production and blockage of MAPK phosphorylation in human monocytic THP-1 cells, indicating anti-inflammatory effects.
Transparency
Dusting Analysis
Tetrahydropalmatine HCL is a pharmacologically active compound with significant safety concerns and is not a commonly used or 'dusted' ingredient in cosmetic formulations. Its potent effects and warnings preclude its casual inclusion in skincare products.
The Formula
Formulation
Stability
Optimal stability is achieved in a mild acidic environment, typically between pH 3 and 5, which facilitates protonation. Degradation may occur under strongly acidic conditions or at elevated temperatures.
Safety
Safety Profile
Tetrahydropalmatine HCL carries significant safety warnings primarily from its recognized pharmacological applications. The Chinese National Medical Products Administration advises against its use in pregnant women and individuals with extrapyramidal disorders. Warnings also include risks of liver impairment, drowsiness, and extrapyramidal symptoms, particularly with overuse or when combined with other central nervous system depressants. Long-term use is not recommended due to potential cardiac and neurotoxic effects, advising caution in patients with heart diseases. PubChem also lists Tetrahydropalmatine as an 'Irritant'.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Due to its potent pharmacological activity, significant safety warnings including potential irritancy and systemic toxicity, and a critical lack of specific topical safety and efficacy data, Tetrahydropalmatine HCL is not suitable for cosmetic formulations.
Related
Similar Ingredients
Finding similar ingredients…